ZNRF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.932200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.295000E-01
Normal-vs-Stage2
9.916800E-01
Normal-vs-Stage3
4.973700E-02
Normal-vs-Stage4
4.863000E-01
Stage1-vs-Stage2
2.068400E-01
Stage1-vs-Stage3
1.593670E-02
Stage1-vs-Stage4
9.247000E-01
Stage2-vs-Stage3
8.760300E-02
Stage2-vs-Stage4
3.569600E-01
Stage3-vs-Stage4
5.610300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.342600E-01
Normal-vs-AfricanAmerican
2.710000E-01
Normal-vs-Asian
8.322800E-01
Caucasian-vs-AfricanAmerican
1.080340E-02
Caucasian-vs-Asian
7.576800E-01
AfricanAmerican-vs-Asian
7.675500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.274400E-01
Normal-vs-Female
9.181400E-01
Male-vs-Female
4.541800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.410000E-01
Normal-vs-Age(41-60Yrs)
6.619200E-01
Normal-vs-Age(61-80Yrs)
8.452600E-01
Normal-vs-Age(81-100Yrs)
6.027200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.589400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.123800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.007590E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.344000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.986300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.997000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.301200E-01
Normal-vs-Daily Drinker
8.656600E-01
Normal-vs-Weekly Drinker
7.352000E-01
Normal-vs-Occasional Drinker
6.361000E-01
Normal-vs-Social Drinker
7.456000E-01
Non Drinker-vs-Daily Drinker
8.668400E-01
Non Drinker-vs-Weekly Drinker
6.024200E-01
Non Drinker-vs-Occasional Drinker
2.903000E-01
Non Drinker-vs-Social Drinker
6.922000E-01
Daily Drinker-vs-Weekly Drinker
7.153600E-01
Daily Drinker-vs-Occasional Drinker
2.427400E-01
Daily Drinker-vs-Social Drinker
8.143200E-01
Weekly Drinker-vs-Occasional Drinker
1.816640E-01
Weekly Drinker-vs-Social Drinker
8.827200E-01
Occasional Drinker-vs-Social Drinker
1.761360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.591770E-01
Normal-vs-Grade 2
4.312200E-02
Normal-vs-Grade 3
1.066400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.638200E-01
Grade 1-vs-Grade 3
5.402200E-01
Grade 1-vs-Grade 4
1.591770E-01
Grade 2-vs-Grade 3
3.565800E-01
Grade 2-vs-Grade 4
4.312200E-02
Grade 3-vs-Grade 4
1.066400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.334400E-01
Normal-vs-NonDiabetic
9.783600E-01
Diabetic-vs-NonDiabetic
9.577800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.077600E-01
Normal-vs-NoPancreatitis
9.328200E-01
Pancreatitis-vs-NoPancreatitis
9.279600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.892000E-01
Normal-vs-N1
9.546400E-01
N0-vs-N1
5.149600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.616400E-01
Normal-vs-TP53-NonMutant
8.423200E-01
TP53-Mutant-vs-TP53-NonMutant
2.688000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
